SCHEDULE 13G
Item 1.
LifeStance Health Group, Inc., Delaware corporation (the “Issuer”)
(b) | Address of Issuer’s Principal Executive Offices |
4800 N. Scottsdale Road, Suite 2300, Scottsdale, Arizona 85251
Item 2.
This Schedule 13G is being filed on behalf of Michael K. Lester
(b) | Address of Principal Business Office or, if none, Residence |
The address of the principal business office of the Reporting Person is c/o LifeStance Health Group, Inc., 4800 N. Scottsdale Road, Suite 2300, Scottsdale, Arizona 85251.
United States
(d) | Title of Class of Securities |
Common stock, par value $0.01 per share (the “Common Stock”)
53228F101
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
This Item 3 is not applicable.
(a) | Amount beneficially owned: |
As of the date hereof, the Reporting Person beneficially owns 15,953,887 shares of Common Stock, representing approximately 4.2% of the outstanding shares of Common Stock.
The percentage of the outstanding shares of Common Stock held by the Reporting Person is based on 378,607,491 shares of Common Stock issued and outstanding as of November 1, 2023 as reported on the Issuer’s 10-Q, filed on November 8, 2023.
See Item 4(a) hereof.
(c) | Number of shares as to which the person has: |